We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lindera obtusiloba Attenuates Oxidative Stress and Airway Inflammation in a Murine Model of Ovalbumin-Challenged Asthma.
- Authors
Lee, Ba-Wool; Ha, Ji-Hye; Shin, Han-Gyo; Jeong, Seong-Hun; Kim, Ju-Hong; Lee, Jihye; Park, Ji-Young; Kwon, Hyung-Jun; Jung, Kyungsook; Lee, Woo-Song; Ryu, Young-Bae; Jeong, Jae-Ho; Lee, In-Chul
- Abstract
Lindera obtusiloba is widespread in northeast Asia and used for treatment of improvement of blood circulation and anti-inflammation. In this study, we investigated anti-inflammatory and anti-oxidant effects of the methanolic extract of L. obtusiloba leaves (LOL) in an ovalbumin (OVA)-challenged allergic asthma model and tumor necrosis factor (TNF)-α-stimulated NCI-H292 cell. Female BALB/c mice were sensitized with OVA by intraperitoneal injection on days 0 and 14, and airway-challenged with OVA from days 21 to 23. Mice were administered 50 and 100 mg/kg of LOL by oral gavage 1 h before the challenge. LOL treatment effectively decreased airway hyper-responsiveness and inhibited inflammatory cell recruitment, Th2 cytokines, mucin 5AC (MUC5AC) in bronchoalveolar lavage fluid in OVA-challenged mice, which were accompanied by marked suppression of airway inflammation and mucus production in the lung tissue. LOL pretreatment inhibited the phosphorylation of mitogen-activated protein kinases (MAPKs) and nuclear factor-kappa B (NF-κB) with suppression of activator protein (AP)-1 and MUC5AC in the lung tissue. LOL also down-regulated expression of inflammatory cytokines, and inhibited the activation of NF-κB in TNF-α-stimulated NCI-H292 cells. LOL elevated the translocation of nuclear factor-erythroid 2-related factor (Nrf-2) into nucleus concurrent with increase of heme oxyngenase-1 (HO-1) and NAD(P)H quinine oxidoreductase 1 (NQO1). Moreover, LOL treatment exhibited a marked increase in the anti-oxidant enzymes activities, whereas effectively suppressed the production of reactive oxygen species and nitric oxide, as well as lipid peroxidation in lung tissue of OVA-challenged mice and TNF-α-stimulated NCI-H292 cells. These findings suggest that LOL might serve as a therapeutic agent for the treatment of allergic asthma.
- Subjects
ASIA; MITOGEN-activated protein kinases; REACTIVE oxygen species; NF-kappa B; TUMOR necrosis factors; OXIDATIVE stress; MUCUS; BLOOD circulation; OVALBUMINS
- Publication
Antioxidants, 2020, Vol 9, Issue 7, p563
- ISSN
2076-3921
- Publication type
Article
- DOI
10.3390/antiox9070563